Del Global inks first eastern European order

Article

Del Global Technologies and its Italian subsidiary, Villa Sistemi Medicali, announced that the government of Lithuania has awarded them an $8.25 million, two-year contract for a variety of x-ray systems.Del Global manufactures general and portable

Del Global Technologies and its Italian subsidiary, Villa Sistemi Medicali, announced that the government of Lithuania has awarded them an $8.25 million, two-year contract for a variety of x-ray systems.

Del Global manufactures general and portable x-ray systems, as well as dental and mammography units. It recently signed an agreement with the European Distribution Organization (SCAN, 8/2/00), granting the EDO the right to act as exclusive distributor of Del Global’s medical imaging systems.

Countries in the EDO include Poland, the Czech Republic, the Slovak Republic, Hungary, Greece, Romania, Turkey, Bulgaria, Yugoslavia, Russia, and others, such as Lithuania, in the Commonwealth of Independent States.

Del Global also announced that the FDA has approved marketing of Villa Sistemi’s dental imaging system in the U.S.

Del Global obtained a 19% stake in Villa Sistemi in January, along with the nonrevocable option to increase its ownership share to 80%, and decided to exercise that option in April (SCAN 5/10/00). Del Global is based in Valhalla, NY, while Villa Sistemi is based in Milan.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.